These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10492800)
21. Tolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF). Pani SP; Das LK; Vanamail P J Commun Dis; 2005 Mar; 37(1):12-7. PubMed ID: 16637395 [TBL] [Abstract][Full Text] [Related]
22. Mass treatment of filariasis using DEC-medicated salt. Liu J; Chen Z; Huang X; Tu Z J Trop Med Hyg; 1992 Apr; 95(2):132-5. PubMed ID: 1560482 [TBL] [Abstract][Full Text] [Related]
23. Effect of Diethylcarbamazine (DEC) on prostaglandin levels in Wuchereria bancrofti infected microfilaraemics. Sankari T; Hoti SL; Das LK; Govindaraj V; Das PK Parasitol Res; 2013 Jun; 112(6):2353-9. PubMed ID: 23525692 [TBL] [Abstract][Full Text] [Related]
24. Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment. Supali T; Djuardi Y; Pfarr KM; Wibowo H; Taylor MJ; Hoerauf A; Houwing-Duistermaat JJ; Yazdanbakhsh M; Sartono E Clin Infect Dis; 2008 May; 46(9):1385-93. PubMed ID: 18419441 [TBL] [Abstract][Full Text] [Related]
25. Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis: comparative efficacy of standard treatment and two semi-annual single-dose treatments. Meyrowitsch DW; Simonsen PE; Makunde WH Trans R Soc Trop Med Hyg; 1996; 90(1):69-73. PubMed ID: 8730317 [TBL] [Abstract][Full Text] [Related]
26. Microfilaraemia, filarial antibody, antigen and immune complex levels in human filariasis before, during and after DEC therapy. A two-year follow-up. Ramaprasad P; Prasad GB; Harinath BC Acta Trop; 1988 Sep; 45(3):245-55. PubMed ID: 2903626 [TBL] [Abstract][Full Text] [Related]
27. Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine-albendazole. Rizzo JA; Belo C; Lins R; Dreyer G Ann Trop Med Parasitol; 2007 Jul; 101(5):423-33. PubMed ID: 17550648 [TBL] [Abstract][Full Text] [Related]
28. A single dose of doxycycline in combination with diethylcarbamazine for treatment of bancroftian filariasis. Sanprasert V; Sujariyakul A; Nuchprayoon S Southeast Asian J Trop Med Public Health; 2010 Jul; 41(4):800-12. PubMed ID: 21073054 [TBL] [Abstract][Full Text] [Related]
29. The effect of diethylcarbamazine treatment of Bancroftian filariasis on the immunological reactivity of microfilaraemic individuals. Lammie PJ; Eberhard ML; Leiva LE; Lowrie RC; Katz SP Trans R Soc Trop Med Hyg; 1988; 82(5):726-9. PubMed ID: 3075359 [TBL] [Abstract][Full Text] [Related]
30. Duration of detection of anti-BmR1 IgG4 antibodies after mass-drug administration (MDA) in Sarawak, Malaysia. Noordin R; Muhi J; Md Idris Z; Arifin N; Kiyu A Trop Biomed; 2012 Mar; 29(1):191-6. PubMed ID: 22543621 [TBL] [Abstract][Full Text] [Related]
31. Bancroftian filariasis: effect of repeated treatment with diethylcarbamazine and albendazole on microfilaraemia, antigenaemia and antifilarial antibodies. Helmy H; Weil GJ; Ellethy AS; Ahmed ES; Setouhy ME; Ramzy RM Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):656-62. PubMed ID: 16414095 [TBL] [Abstract][Full Text] [Related]
32. A placebo-controlled double-blind trial for the treatment of bancroftian filariasis with ivermectin or diethylcarbamazine. Sabry M; Gamal H; el-Masry N; Kilpatrick ME Trans R Soc Trop Med Hyg; 1991; 85(5):640-3. PubMed ID: 1780996 [TBL] [Abstract][Full Text] [Related]
33. Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka. Gunawardena S; Sri Ranganathan S; Fernandopulle R Trop Med Int Health; 2008 Sep; 13(9):1153-8. PubMed ID: 18631319 [TBL] [Abstract][Full Text] [Related]
34. Adverse reactions following mass drug administration with diethylcarbamazine in lymphatic filariasis endemic areas in the Northeast of Brazil. Lima AW; Medeiros Z; Santos ZC; Costa GM; Braga C Rev Soc Bras Med Trop; 2012 Dec; 45(6):745-50. PubMed ID: 23295880 [TBL] [Abstract][Full Text] [Related]
35. Tolerance to diethylcarbamazine-medicated salt in individuals infected with Onchocerca volvulus. Meyrowitsch DW; Simonsen PE; Magnussen P Trans R Soc Trop Med Hyg; 2000; 94(4):444-8. PubMed ID: 11127254 [TBL] [Abstract][Full Text] [Related]
36. Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis. Adinarayanan S; Critchley J; Das PK; Gelband H Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD003758. PubMed ID: 17253495 [TBL] [Abstract][Full Text] [Related]
37. The effect of HIV on filarial-specific antibody response before and after treatment with diethylcarbamazine in Wuchereria bancrofti infected individuals. Petersen HH; Nielsen NO; Monrad J; Magesa SM; Simonsen PE Parasitol Int; 2009 Jun; 58(2):141-4. PubMed ID: 19567236 [TBL] [Abstract][Full Text] [Related]
38. Cellular immune competence in bancroftian filariasis. Mistry SS; Subrahmanyam D J Trop Med Hyg; 1985 Dec; 88(6):383-8. PubMed ID: 3915514 [TBL] [Abstract][Full Text] [Related]
39. Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India. Ramaiah KD; Vanamail P; Yuvaraj J; Das PK Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):431-7. PubMed ID: 21601901 [TBL] [Abstract][Full Text] [Related]
40. Persistence of microfilaremia in bancroftian filariasis after diethylcarbamazine citrate therapy. Eberhard ML; Lowrie RC; Lammie PJ Trop Med Parasitol; 1988 Jun; 39(2):128-30. PubMed ID: 3051291 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]